Related Experiment Video
Updated: Sep 15, 2025

An Assay for Quantifying Protein-RNA Binding in Bacteria
Published on: June 12, 2019
Elucidating the role of mycobacteriophage D29-encoded Gp36 in DNA binding and phage gene expression regulation
Swathy Sasidharan Pillai1, Vikas Jain1
1Microbiology and Molecular Biology Laboratory, Department of Biological Sciences, Indian Institute of Science Education and Research (IISER) Bhopal, Madhya Pradesh, 462066, India.
Abstract:
Bacteriophage infection leading to progeny production in a bacterial host requires timely expression of phage genes that is regulated by various phage- and bacteria-encoded factors. Mycobacteriophage D29, a lytic bacteriophage, is capable of infecting several mycobacterial species, including pathogenic Mycobacterium tuberculosis. Genomic characterization of D29 revealed two distinct promoters present at extreme ends of the genome that govern expression of phage genes. However, D29-derived transcriptional factors that regulate such expression remain largely unexplored. Here, we have characterized D29-encoded Gp36. We show that Gp36 binds to GC-rich direct repeats in sequence-specific manner. Gp36 makes weak homo-oligomer in vitro, with residues I25 and L35 being important for homo-oligomerization. We further show that Gp36 belongs to MerR family of transcriptional regulators, and represses expression of D29 genes; bacteriophage lacking gp36 shows higher expression of those early and late genes that are downstream to the Gp36 binding site in the genome. Such alteration of gene expression in mutated phage resulted in lower phage titer, although plaque size and host lysis timing remained unaltered. We thus present Gp36 as a transcriptional repressor of D29 with a regulatory role in modulating D29 gene expression, and envisage its engineering as a potential approach for developing phage therapeutics.
Insights
Mycobacteriophage D29's Gp36 protein acts as a transcriptional repressor, controlling phage gene expression. Understanding Gp36 is key for developing novel phage therapeutics against Mycobacterium tuberculosis.
Area of Science:
- Microbiology
- Molecular Biology
- Genetics
Background:
- Bacteriophage gene expression is tightly regulated by phage and host factors.
- Mycobacteriophage D29 infects Mycobacterium tuberculosis, necessitating study of its regulatory mechanisms.
- Key transcriptional regulators of D29 remain largely uncharacterized.
Purpose of the Study:
- To characterize the D29-encoded Gp36 protein.
- To elucidate the regulatory role of Gp36 in D29 gene expression.
- To explore the potential of Gp36 engineering for phage therapeutics.
Main Methods:
- Sequence-specific DNA-binding assays for Gp36.
- In vitro homo-oligomerization studies of Gp36.
- Analysis of gene expression in wild-type and gp36-deficient D29 bacteriophages.
Main Results:
- Gp36 binds GC-rich direct repeats in a sequence-specific manner.
- Gp36 is a MerR family transcriptional repressor, negatively regulating downstream D29 genes.
- Loss of gp36 leads to increased early and late gene expression and reduced phage titer.
Conclusions:
- Gp36 functions as a transcriptional repressor in Mycobacteriophage D29.
- Gp36 plays a crucial role in modulating D29 gene expression.
- Engineering Gp36 offers a potential strategy for developing phage-based therapeutics.
Related Concept Videos
DNA Bacteriophages
Lysogenic Cycle of Bacteriophages
Viral Replication: Lysogenic Cycle
Lytic Cycle of Bacteriophages
Transduction
Viral Replication: Lytic Cycle

